Munich-based holding company Mutares has cleared a critical balance-sheet hurdle just days before its annual general meeting. The group confirmed it navigated the June 29 deadline for a key bond covenant, eliminating a risk that had hung over the stock for months. The breach, which occurred at the end of 2025, saw the ratio of net debt to equity exceed agreed limits due to valuation effects, a slow fourth quarter for transactions and higher leasing liabilities. Bondholders granted a temporary waiver that expired on the 29th, and the company met the conditions in time.
The decisive factor was the timing of individual deals. Mutares closed the acquisition of Wärtsilä’s gas solutions business on June 1, embedding it in the balance sheet and improving the equity metric before the deadline. The far larger purchase of SABIC’s engineering thermoplastics division, however, will only contribute structurally after the date — it is expected to close in the second half of the year. That transaction, the largest in Mutares’ history, carries an enterprise value of $450 million. The unit generates around $2.5 billion in annual revenue and employs roughly 2,900 people across eight sites. It will form the core of a new “Chemicals & Materials” segment.
While the covenant relief provides short-term breathing room, the company is simultaneously pushing ahead with a structured bond buyback. Management plans to reduce outstanding bonds from €385 million to between €250 million and €300 million by the end of 2026. In the current quarter, at least €25 million of the 2023/2027 note will be retired, with similar amounts to follow each subsequent quarter. Funding comes from asset sales — notably the previously signed disposal of the NEM Energy Group to Hyundai Heavy Industries Power Systems, which is slated to close in the third quarter. The purchase price remains undisclosed.
On the growth side, the SABIC deal is the headline act, but the pipeline also includes potential bolt-on acquisitions in the U.S., where Mutares already has a Chicago office and is planning a second base. The American target universe covers possible purchases with a combined revenue volume of €4.8 billion. Management is also reviewing options for fire-engine specialist Magirus, which boasts an order backlog of more than €880 million, securing production into 2027. A sale or initial public offering could provide a significant catalyst, though no final decision has been reached.
Should investors sell immediately? Or is it worth buying Mutares?
That uncertainty is reflected in the share price. The stock currently trades at around €28.25, having lost 3.75% over the past week and 6.35% since the start of the year. It sits roughly 21% below the 52-week high of €35.60, just under the 200-day moving average, with a relative strength index of 47.7 signaling neutral momentum. The yield on the proposed base dividend of €2.00 per share amounts to roughly 7.1% at the current level, but no performance dividend will be paid for 2025 — that payout stream resumes only after major successful exits.
The AGM on July 3 will be a test of management’s ability to balance debt reduction with shareholder returns. For 2026, Mutares targets consolidated revenue of €7.9 billion to €9.1 billion and net profit of between €165 million and €200 million. First-quarter revenue rose 10% to about €1.68 billion, but the holding company posted a loss of €0.9 million compared with a €29.5 million profit a year earlier, when the partial sale of Steyr Motors boosted earnings. The turnaround this year hinges on a steady flow of exits in the second half.
The timing of those disposals is the wild card. The NEM Energy deal still requires regulatory approvals, and the Magirus process remains in the evaluation phase. Delays would put the annual profit target at risk and push a future performance dividend further out of reach. Mutares has cleared one immediate hurdle, but the next catalyst — whether it is a closing in South Korea or a decision on the fire-truck unit — will determine whether the stock can recapture lost ground.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from July 1 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 1.
Mutares: Buy or sell? Read more here...









